Funder: Stanford University
Due Dates (Anticipated): October 2027 (Proposal submission)
Funding Amounts: $75,000 for a one-year funding period
Summary: Supports Stanford investigators accelerating basic, translational, clinical, and population-based cancer research and investigator-initiated clinical trials.
Key Information: PI and Co-PI roles are limited to Stanford Academic Council members and University Medical Line faculty.
Description
The Stanford Cancer Institute (SCI) Innovation Awards support projects that accelerate basic, translational, clinical, and population-based cancer research, including the development of investigator-initiated clinical trials. The program advances SCI’s mission to reduce cancer mortality and improve cancer care through research, prevention, treatment, education, and outreach. Its aims include translating scientific discovery into clinical research and patient care, improving prevention and early detection, and developing more precise diagnosis and effective treatment.
Priorities include multidisciplinary collaborations involving Stanford faculty beyond the School of Medicine or spanning SCI’s six research programs. SCI also prioritizes community outreach and engagement research, investigator-initiated clinical trials, non-viral technologies for delivering genes to tumors or tissues, and projects planning external peer-reviewed funding applications, preferably to the National Cancer Institute.
